Saul Centers Inc. (BFS)
NYSE NYSE Primary 
XFRA 
Saul Centers Declares Quarterly Dividends
BETHESDA, Md. , June 12, 2025 /PRNewswire/ -- Saul Centers, Inc. (NYSE: BFS) has declared a quarterly dividend of $0.59 per share on its common stock, to be paid on July 31, 2025, to holders of record on July 15, 2025.
Saul Centers (BFS) Q1 FFO Miss Estimates
Saul Centers (BFS) came out with quarterly funds from operations (FFO) of $0.71 per share, missing the Zacks Consensus Estimate of $0.73 per share. This compares to FFO of $0.80 per share a year ago.
Saul Centers, Inc. Reports First Quarter 2025 Earnings
BETHESDA, Md. , May 8, 2025 /PRNewswire/ -- Saul Centers, Inc. (NYSE: BFS), an equity real estate investment trust ("REIT"), announced operating results for the quarter ended March 31, 2025 ("2025 Quarter").
Amneal and Apiject to Expand Sterile and Blow-Fill-Seal (BFS) Capabilities for Advanced Pharmaceutical Manufacturing in the U.S.
-Adds BFS platform technology to provide large-scale production capacity for sterile drug dosage forms, including injectables, ophthalmics and inhalation -Expands Amneal's extensive domestic pharmaceutical manufacturing footprint BRIDGEWATER, N.J., May 08, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”), an American biopharmaceutical company, and Apiject Systems, Corp. (“Apiject”), a medical technology company focused on advanced drug delivery, today announced a strategic collaboration to expand domestic production of Apiject's BFS-based injectable platform at Amneal's Brookhaven, NY facility.
Saul Centers: Mixed Q4 And DC Headwinds Limit Upside
Saul Centers has underperformed over the past decade, with shares losing 35% and facing headwinds from federal government downsizing in the DC/Baltimore area. The company's Q4 results were impacted by project accounting, with a significant increase in costs due to the completion of Twinbrook Quarter Phase 1. High occupancy rates are offset by cost inflation and office space weakness, limiting the potential for same property growth and dividend increases.
Saul Centers (BFS) Q4 FFO and Revenues Lag Estimates
Saul Centers (BFS) came out with quarterly funds from operations (FFO) of $0.63 per share, missing the Zacks Consensus Estimate of $0.68 per share. This compares to FFO of $0.79 per share a year ago.
Saul Centers, Inc. Reports Fourth Quarter 2024 Earnings
BETHESDA, Md. , Feb. 28, 2025 /PRNewswire/ -- Saul Centers, Inc. (NYSE: BFS), an equity real estate investment trust ("REIT"), announced operating results for the quarter ended December 31, 2024 ("2024 Quarter").
Saul Centers, Inc. Announces Tax Treatment of 2024 Dividends
BETHESDA, Md. , Jan. 23, 2025 /PRNewswire/ -- Saul Centers, Inc. (NYSE: BFS), an equity real estate investment trust (REIT), announced today the income tax treatment of its 2024 dividends.
What Makes Saul Centers (BFS) a New Buy Stock
Saul Centers (BFS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Saul Centers: Access To Affluent Shoppers Will Fuel Growth
Saul Centers, a mid-cap REIT, is now trading at a discount, making it an attractive investment for its Washington DC properties. The company has a strong dividend yield of 6% and stable growth potential, primarily through rental rate increases. Saul's high insider ownership and low market communication make it unique, but also slightly riskier due to high leverage.
Saul Centers (BFS) Q3 FFO and Revenues Beat Estimates
Saul Centers (BFS) came out with quarterly funds from operations (FFO) of $0.83 per share, beating the Zacks Consensus Estimate of $0.80 per share. This compares to FFO of $0.76 per share a year ago.
Saul Centers, Inc. Reports Third Quarter 2024 Earnings
BETHESDA, Md. , Nov. 7, 2024 /PRNewswire/ -- Saul Centers, Inc. (NYSE: BFS), an equity real estate investment trust ("REIT"), announced operating results for the quarter ended September 30, 2024 ("2024 Quarter").
